Whitepaper

Current Treatment Challenges Of IO Refractory Patients And Clinical Development Of Therapies Targeting These Patients
Harnessing the power of own immune cells, Immuno-oncology therapies are carving out a nice in oncology treatment landscape
CURRENT TREATMENT CHALLENGES OF IO REFRACTORY PATIENTS AND CLINICAL DEVELOPMENT OF THERAPIES TARGETING THESE PATIENTS

More Whitepapers / Newsletters

Cancer In The United States(Vol 1, Issue 2)
Cancer In The United States(Vo...

US Cancer Statistics show that more than half a million suffer from this disease, which is the second leading cause of death in the country. The newsletter Cancer in the US substantiates the increasin...

Chronic Pancreatitis
Chronic Pancreatitis

Chronic Pancreatitis is an inflammation of the pancreas that can be a result of calcium stones and cysts, acute inflammation, cystic fibrosis, unhealthy lifestyle habits, certain autoimmune disorders...

Pompe Disease Newsletter
Pompe Disease

An autosomal metabolic disorder – Pompe disease results in deterioration of organs and tissues as a consequence of excess accumulation of glycogen in muscle and nerve cells throughout the body. Also c...

COVID-19 Whitepaper
COVID-19

Over the last months, the world has faced one of the most unexpected challenges in the form of a novel coronavirus, SARS-CoV-2, infection. Through the whitepaper, DelveInsight aims to make its clients...

Systemic Scleroderma Market
Systemic Scleroderma

Systemic scleroderma (SSC or systemic sclerosis) is an autoimmune disorder that results into scar tissues (fibrosis) on the skin and internal organs. The prevalence of systemic scleroderma is about 30...